Figure 4From: SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation Levels of secreted SPARC increased during IM therapy. Secreted protein was evaluated by ELISA in CML 10 patients at D, 6 of which followed during TKI therapy. Data are expressed as means ± S.D.Back to article page